Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.245 USD | +2.05% | -11.07% | -26.23% |
06-25 | Needham Lowers Price Target on G1 Therapeutics to $6 From $12, Maintains Buy Rating | MT |
06-25 | HC Wainwright Lowers G1 Therapeutics Price Target to $3 From $9, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.23% | 115M | |
+16.32% | 122B | |
+21.71% | 116B | |
+22.18% | 27.03B | |
-21.46% | 20.36B | |
-16.89% | 16.43B | |
-18.63% | 15.91B | |
-44.74% | 15.6B | |
+62.23% | 14.94B | |
+3.07% | 13.59B |
- Stock Market
- Equities
- GTHX Stock
- News G1 Therapeutics, Inc.
- G1 Therapeutics Gets Continuation Recommendation From Data Monitoring Committee for Phase 3 Breast Cancer Study